Bell Potter Reaffirms Their Buy Rating on Lumos Diagnostics Holdings Ltd. (LDX)

Bell Potter reaffirmed its Buy rating on Lumos Diagnostics Holdings Ltd. (LDX) with a price target of A$0.25, according to a report released today by analyst Martyn Jacobs. The note points to company performance and market positioning: for the quarter ended December 31, Lumos posted quarterly revenue of A$6.23 million and a GAAP net loss of A$4.97 million. In the prior year period, revenue was A$6.31 million and GAAP net loss was A$2.8 million. TipRanks data cited an analyst track record of -19.0% average return and 17.14% success rate. Overall, the Street consensus is a Moderate Buy with an average A$0.25 target, and insider activity from seven insiders is described as positive.